{
    "Trade/Device Name(s)": [
        "AU Bicarbonate Reagent"
    ],
    "Submitter Information": "Beckman Coulter Inc.",
    "510(k) Number": "K131546",
    "Predicate Device Reference 510(k) Number(s)": [
        "K960035"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "KHS"
    ],
    "Summary Letter Date": "October 9, 2013",
    "Summary Letter Received Date": "August 29, 2013",
    "Submission Date": "April 24, 2013",
    "Regulation Number(s)": [
        "21CFR862.1160"
    ],
    "Regulation Name(s)": [
        "Bicarbonate/carbon dioxide test system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Bicarbonate"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma"
    ],
    "Specimen Container(s)": [
        "Sodium Heparin tube",
        "Lithium Heparin tube"
    ],
    "Instrument(s)/Platform(s)": [
        "Beckman Coulter AU analyzers"
    ],
    "Method(s)/Technology(ies)": [
        "Enzymatic photometric"
    ],
    "Methodologies": [
        "Enzymatic method",
        "Photometric measurement"
    ],
    "Submission Type(s)": [
        "Reagent",
        "Calibrator"
    ],
    "Document Summary": "FDA 510(k) summary for AU Bicarbonate Reagent for quantitative measurement of bicarbonate in human serum and plasma using Beckman Coulter AU analyzers",
    "Indications for Use Summary": "Intended for quantitative determination of bicarbonate in human serum and plasma on Beckman Coulter AU analyzers to aid diagnosis and treatment of disorders involving acid-base balance",
    "fda_folder": "Clinical Chemistry"
}